RxDoctor Payments DataLook up a doctor →

Lori Davidson, MD

Obstetrics & Gynecology · Greenwood, INNPI 1770583734

Payments from drug & device makers

$53,709in general payments, 2019–2025

Across 773 payments — averaging $69.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$23K
  • Astellas Pharma US Inc$19K
  • Myovant Sciences Inc.$2K
  • Duchesnay USA Incorporated$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Novo Nordisk$859
  • plus $6K from 46 others

What the payments were for

  • Consulting fees$3,6157%
  • Speaking & faculty fees$36,22567%
  • Travel & lodging$1,4993%
  • Food & beverage$11,78322%
  • Education$5451%
  • Gifts$420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,709 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.

See all obstetrics & gynecology providers in Indiana

Medicare billing

Part B allowed, 2024
$28,795
Medicare patients
142
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron31$27,636
Estradiol59$4,542
Risedronate Sodium37$3,485
Raloxifene Hcl22$881
ProgesteroneProgesterone, Micronized23$660
Bupropion XlBupropion Hcl28$626
Escitalopram Oxalate22$408
Duloxetine Hcl25$391
Levothyroxine Sodium36$331
Terconazole11$291
Alendronate Sodium52$280
Sertraline Hcl15$175
Fluoxetine Hcl31$123
Acyclovir16$103
Buspirone Hcl17$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$19,016$27,63631 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$33136 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$59$10316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.

Other obstetrics & gynecology in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →